-25% NOW Balsam Fir Needle Oil / 100% Pure Abies Balsamea / 30 ml 11.50 / 22.49
A listening summary cannot assess those risks or triage symptoms
GLP-1 AND GIP Given the extensive clinical experience with GLP-1 RAs and the established safety profile in cardiovascular disease settings, peptide multi-agonists have been developed to target multihormonal peptide-secreting enteroendocrine cells.8 Due to their glucose-lowering functions, the combination of GLP-1 and GIP hormones is one of the most attractive strategies for treating T2DM.8, 9 GLP-1 was first identified as a cleavage product of preproglucagon generated by L cells in the small intestine and functions to increase postprandial insulin production and lower blood glucose.10, 11, 12, 13 Since its discovery, efforts have focused on extending GLP-1 agonist activity through structural changes.14 Liraglutide and semaglutide, two long-acting GLP-1 RAs, have been authorized for the treatment of T2DM and obesity

The Rodent Study Findings During the development of tirzepatide, researchers observed that rats and mice exposed to high doses of the drug developed a specific type of thyroid tumour called Medullary Thyroid Carcinoma (MTC)
Both medications use a gradual dose escalation schedule specifically to minimize early side effects